Literature DB >> 18030362

Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.

Wendy J Huss1, Danny R Gray, Keyvan Tavakoli, Meghan E Marmillion, Lori E Durham, Mac A Johnson, Norman M Greenberg, Gary J Smith.   

Abstract

Following castration, the transgenic adenocarcinoma of mouse prostate (TRAMP) model demonstrates rapid development of SV40-Tag-driven poorly differentiated tumors that express neuroendocrine cell markers. The cell population dynamics within the prostates of castrated TRAMP mice were characterized by analyzing the incorporation of 5-bromodeoxyuridine (BrdUrd) and the expression of SV40-Tag, synaptophysin, and androgen receptor (AR). Fourteen days postcastration, the remaining epithelial cells and adenocarcinoma cells were nonproliferative and lacked detectable SV40-Tag or synaptophysin expression. In contrast, morphologically distinct intraglandular foci were identified which expressed SV40-Tag, synaptophysin, and Ki67, but that lacked AR expression. These proliferative SV40-Tag and synaptophysin-expressing intraglandular foci were associated with the rare BrdUrd-retaining cells. These foci expanded rapidly in the postcastration prostate environment, in contrast to the AR- and SV40-Tag-expressing adenocarcinoma cells that lost SV40-Tag expression and underwent apoptosis after castration. Intraglandular foci of synaptophysin-expressing cells were also observed in the prostates of intact TRAMP mice at a comparable frequency; however, they did not progress to rapidly expanding tumors until much later in the life of the mice. This suggests that the foci of neuroendocrine-like cells that express SV40-Tag and synaptophysin, but lack AR, arise independent of androgen-deprivation and represent the source of the poorly differentiated tumors that are the lethal phenotype in the TRAMP model.

Entities:  

Keywords:  Prostate cancer; TRAMP; androgen-insensitive; neuroendocrine; synaptophysin

Mesh:

Substances:

Year:  2007        PMID: 18030362      PMCID: PMC2077885          DOI: 10.1593/neo.07562

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  45 in total

Review 1.  Prostate epithelial stem cells.

Authors:  S Rizzo; G Attard; D L Hudson
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

2.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.

Authors:  P J Kaplan; S Mohan; P Cohen; B A Foster; N M Greenberg
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

4.  Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer.

Authors:  Aarti R Uzgare; Paula J Kaplan; Norman M Greenberg
Journal:  Prostate       Date:  2003-05-01       Impact factor: 4.104

5.  Regulation of Apoptosis in the Prostate Gland by Androgenic Steroids.

Authors: 
Journal:  Trends Endocrinol Metab       Date:  1999-03       Impact factor: 12.015

Review 6.  Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status.

Authors:  H Bonkhoff
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

7.  Expression of Foxa transcription factors in the developing and adult murine prostate.

Authors:  Janni Mirosevich; Nan Gao; Robert J Matusik
Journal:  Prostate       Date:  2005-03-01       Impact factor: 4.104

8.  Neuroendocrine differentiation in human prostatic tumor models.

Authors:  M A Noordzij; W M van Weerden; C M de Ridder; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

Review 9.  Cellular and molecular biology of the prostate: stem cell biology.

Authors:  Jack A Schalken; Geert van Leenders
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

10.  Differential expression of cell cycle regulatory molecules and evidence for a "cyclin switch" during progression of prostate cancer.

Authors:  Lisette A Maddison; Wendy J Huss; Roberto M Barrios; Norman M Greenberg
Journal:  Prostate       Date:  2004-03-01       Impact factor: 4.104

View more
  34 in total

1.  Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity.

Authors:  Silvana G P Campos; Bianca F Gonçalves; Wellerson R Scarano; Lara S Corradi; Fernanda C A Santos; Ana M G Custodio; Patricia S L Vilamaior; Rejane M Góes; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

Review 2.  The genomic revolution and endocrine pathology.

Authors:  Suzana S Couto; Robert D Cardiff
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

3.  Neuronal Trans-Differentiation in Prostate Cancer Cells.

Authors:  Andrew Farach; Yi Ding; MinJae Lee; Chad Creighton; Nikki A Delk; Michael Ittmann; Brian Miles; David Rowley; Mary C Farach-Carson; Gustavo E Ayala
Journal:  Prostate       Date:  2016-07-12       Impact factor: 4.104

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Inactivation of LGI1 expression accompanies early stage hyperplasia of prostate epithelium in the TRAMP murine model of prostate cancer.

Authors:  John K Cowell; Karen Head; Padmaja Kunapuli; Mary Vaughan; Ellen Karasik; Barbara Foster
Journal:  Exp Mol Pathol       Date:  2009-09-22       Impact factor: 3.362

Review 6.  Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.

Authors:  William Hankey; Zhong Chen; Qianben Wang
Journal:  Cancer Res       Date:  2020-02-24       Impact factor: 12.701

7.  MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.

Authors:  Tsuyoshi Iwata; Denise Schultz; Jessica Hicks; Gretchen K Hubbard; Laura N Mutton; Tamara L Lotan; Carlise Bethel; Matthew T Lotz; Srinivasan Yegnasubramanian; William G Nelson; Chi V Dang; MengMeng Xu; Uzoma Anele; Cheryl M Koh; Charles J Bieberich; Angelo M De Marzo
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

8.  Characterization of preclinical models of prostate cancer using PET-based molecular imaging.

Authors:  Sara Belloli; Elena Jachetti; Rosa M Moresco; Maria Picchio; Michela Lecchi; Silvia Valtorta; Massimo Freschi; Rodrigo Hess Michelini; Matteo Bellone; Ferruccio Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-11       Impact factor: 9.236

9.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

10.  Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis.

Authors:  Lara H El Touny; Partha P Banerjee
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.